Primary cutaneous follicle centre lymphoma pathophysiology: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
=== | |||
===Gross Pathology=== | |||
<gallery widths=200px> | <gallery widths=200px> | ||
Image:Primary cutaneous follicle centre lymphoma images.jpg|Multinodular mass on the scalp (A) and spectacular response after the second chemotherapy course (B).<ref name=biomedcentral> Primary cutaneous follicle centre lymphoma. BioMed Central. https://biomarkerres.biomedcentral.com/articles/10.1186/2050-7771-2-7. Accessed on March 01, 2016</ref> | Image:Primary cutaneous follicle centre lymphoma images.jpg|Multinodular mass on the scalp (A) and spectacular response after the second chemotherapy course (B).<ref name=biomedcentral> Primary cutaneous follicle centre lymphoma. BioMed Central. https://biomarkerres.biomedcentral.com/articles/10.1186/2050-7771-2-7. Accessed on March 01, 2016</ref> | ||
</gallery> | |||
===Microscopic Pathology=== | |||
<gallery widths=200px> | |||
Image:Primary cutaneous follicle centre lymphoma image 2.jpg|Histopatological fingings. Biopsy of the mass of the scalp showing a dense and diffuse dermal infiltrate with nodular growth pattern (A) consisted of large atypical lymphocytes (H&E) (B), which are positive for CD20 (C) and Bcl6 (D) and negative for Bcl2 (E) on immunohistochemical staining. Bone marrow biopsy showing a hypercellular bone marrow with proliferation of megakaryocytes with hyperlobulated nuclei, sometimes in loose clusters (H&E) (F), positive for CD61 on immunohistochemical staining (G).<ref name=biomedcentral> Primary cutaneous follicle centre lymphoma. BioMed Central. https://biomarkerres.biomedcentral.com/articles/10.1186/2050-7771-2-7. Accessed on March 01, 2016</ref> | Image:Primary cutaneous follicle centre lymphoma image 2.jpg|Histopatological fingings. Biopsy of the mass of the scalp showing a dense and diffuse dermal infiltrate with nodular growth pattern (A) consisted of large atypical lymphocytes (H&E) (B), which are positive for CD20 (C) and Bcl6 (D) and negative for Bcl2 (E) on immunohistochemical staining. Bone marrow biopsy showing a hypercellular bone marrow with proliferation of megakaryocytes with hyperlobulated nuclei, sometimes in loose clusters (H&E) (F), positive for CD61 on immunohistochemical staining (G).<ref name=biomedcentral> Primary cutaneous follicle centre lymphoma. BioMed Central. https://biomarkerres.biomedcentral.com/articles/10.1186/2050-7771-2-7. Accessed on March 01, 2016</ref> | ||
</gallery> | </gallery> | ||
Revision as of 18:37, 1 March 2016
|
Primary cutaneous follicle centre lymphoma Microchapters |
|
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary cutaneous follicle centre lymphoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma pathophysiology |
|
FDA on Primary cutaneous follicle centre lymphoma pathophysiology |
|
CDC on Primary cutaneous follicle centre lymphoma pathophysiology |
|
Primary cutaneous follicle centre lymphoma pathophysiology in the news |
|
Blogs on Primary cutaneous follicle centre lymphoma pathophysiology |
|
Directions to Hospitals Treating Splenic marginal zone lymphoma |
|
Risk calculators and risk factors for Primary cutaneous follicle centre lymphoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Pathophysiology
Gross Pathology
-
![Multinodular mass on the scalp (A) and spectacular response after the second chemotherapy course (B).[1]](/images/6/6d/Primary_cutaneous_follicle_centre_lymphoma_images.jpg)
Multinodular mass on the scalp (A) and spectacular response after the second chemotherapy course (B).[1]
![Multinodular mass on the scalp (A) and spectacular response after the second chemotherapy course (B).[1]](/index.php/File:Primary_cutaneous_follicle_centre_lymphoma_images.jpg)
Microscopic Pathology
-
![Histopatological fingings. Biopsy of the mass of the scalp showing a dense and diffuse dermal infiltrate with nodular growth pattern (A) consisted of large atypical lymphocytes (H&E) (B), which are positive for CD20 (C) and Bcl6 (D) and negative for Bcl2 (E) on immunohistochemical staining. Bone marrow biopsy showing a hypercellular bone marrow with proliferation of megakaryocytes with hyperlobulated nuclei, sometimes in loose clusters (H&E) (F), positive for CD61 on immunohistochemical staining (G).[1]](/images/2/21/Primary_cutaneous_follicle_centre_lymphoma_image_2.jpg)
Histopatological fingings. Biopsy of the mass of the scalp showing a dense and diffuse dermal infiltrate with nodular growth pattern (A) consisted of large atypical lymphocytes (H&E) (B), which are positive for CD20 (C) and Bcl6 (D) and negative for Bcl2 (E) on immunohistochemical staining. Bone marrow biopsy showing a hypercellular bone marrow with proliferation of megakaryocytes with hyperlobulated nuclei, sometimes in loose clusters (H&E) (F), positive for CD61 on immunohistochemical staining (G).[1]
![Histopatological fingings. Biopsy of the mass of the scalp showing a dense and diffuse dermal infiltrate with nodular growth pattern (A) consisted of large atypical lymphocytes (H&E) (B), which are positive for CD20 (C) and Bcl6 (D) and negative for Bcl2 (E) on immunohistochemical staining. Bone marrow biopsy showing a hypercellular bone marrow with proliferation of megakaryocytes with hyperlobulated nuclei, sometimes in loose clusters (H&E) (F), positive for CD61 on immunohistochemical staining (G).[1]](/index.php/File:Primary_cutaneous_follicle_centre_lymphoma_image_2.jpg)
References
- ↑ 1.0 1.1 Primary cutaneous follicle centre lymphoma. BioMed Central. https://biomarkerres.biomedcentral.com/articles/10.1186/2050-7771-2-7. Accessed on March 01, 2016